India to Mauritius: Dapagliflozin Export Trade Route
India has recorded 1,023 verified shipments of Dapagliflozin exported to Mauritius, representing a combined trade value of $2.3M USD. This corridor is served by 26 active Indian exporters, with an average shipment value of $2.3K USD. The leading Indian exporter is SAVA HEALTHCARE LIMITED, which accounts for 26% of total export value with 497 shipments worth $600.2K USD. On the buying side, REGENCY PHARMA LIMITED is the largest importer in Mauritius with $1.3M USD in purchases. The top 3 suppliers — SAVA HEALTHCARE LIMITED, HEXA HEALTHCARE PVT LTD, MICRO LABS LIMITED — together control 62% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mauritius Dapagliflozin corridor is one of India's established pharmaceutical export routes, with 1,023 shipments documented worth a combined $2.3M USD. The route is dominated by SAVA HEALTHCARE LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's dapagliflozin manufacturing sector.
Across 26 active suppliers, the average shipment value stands at $2.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (30%) and air (70%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 12.0%, placing it at rank #5 among India's top dapagliflozin export destinations globally.
On the import side, key buyers of Indian dapagliflozin in Mauritius include REGENCY PHARMA LIMITED, FTM (MAURITIUS) LIMITED, Ducray Lenoir Ltd and 27 others. REGENCY PHARMA LIMITED is the single largest importer with 661 shipments valued at $1.3M USD.
